Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
XBIT

XBIT - XBiotech Inc Stock Price, Fair Value and News

$2.53+0.21 (+9.05%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

XBIT Price Action

Last 7 days

11.0%

Last 30 days

10.5%

Last 90 days

-15.1%

Trailing 12 Months

-62.4%

XBIT RSI Chart

XBIT Valuation

Market Cap

77.1M

Price/Earnings (Trailing)

-2.65

Price/Sales (Trailing)

11.76

EV/EBITDA

2.62

Price/Free Cashflow

-3.23

XBIT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

XBIT Fundamentals

XBIT Revenue

Revenue (TTM)

6.6M

Rev. Growth (Yr)

-39.76%

Rev. Growth (Qtr)

-6.73%

XBIT Earnings

Earnings (TTM)

-29.2M

Earnings Growth (Yr)

-19.8%

Earnings Growth (Qtr)

-242.14%

XBIT Profitability

EBT Margin

-442.85%

Return on Equity

-17.45%

Return on Assets

-16.91%

Free Cashflow Yield

-30.92%

XBIT Investor Care

Shares Dilution (1Y)

0.01%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20258.7M7.5M6.6M0
202410.3M10.5M10.3M9.8M
20237.9M9.0M10.5M10.4M
202214.8M11.2M7.6M4.0M
202136.2M25.2M19.2M18.4M
202017.9M26.6M35.3M44.0M
2019414.5K358.5K508.5K9.2M
2018368.5K361.5K338.5K400.5K
2017125.1K201.3K277.4K353.5K
201600049.0K
20150000
20140000
20130000
Get all data in R, Python etc through our Historical Stock Data APIs

About XBiotech Inc

XBIT
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
 CEO
 WEBSITExbiotech.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES84

XBiotech Inc Frequently Asked Questions

What is the ticker symbol for XBiotech Inc? What does XBIT stand for in stocks?

XBIT is the stock ticker symbol of XBiotech Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of XBiotech Inc (XBIT)?

As of Wed Dec 03 2025, market cap of XBiotech Inc is 77.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XBIT stock?

You can check XBIT's fair value in chart for subscribers.

Is XBiotech Inc a good stock to buy?

The fair value guage provides a quick view whether XBIT is over valued or under valued. Whether XBiotech Inc is cheap or expensive depends on the assumptions which impact XBiotech Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XBIT.

What is XBiotech Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, XBIT's PE ratio (Price to Earnings) is -2.65 and Price to Sales (PS) ratio is 11.76. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XBIT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on XBiotech Inc's stock?

In the past 10 years, XBiotech Inc has provided -0.115 (multiply by 100 for percentage) rate of return.